McKinley Capital Management’s Genmab GMAB Stock Holding History

McKinley Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,058	Closed	-$284K	–	165
2023 Q3	$284K	Sell	8,058 -4,295	-35%	-$164K	0.04%	162
2023 Q2	$470K	Sell	12,353 -340	-3%	-$13.6K	0.06%	154
2023 Q1	$479K	Sell	12,693 -393	-3%	-$15.1K	0.06%	155
2022 Q4	$555K	Sell	13,086 -438	-3%	-$18K	0.07%	154
2022 Q3	$434K	Buy	+13,524	New	+$475K	0.06%	160
2021 Q1	–	Sell	-11,008	Closed	-$447K	–	186
2020 Q4	$447K	Sell	11,008 -794	-7%	-$29.7K	0.03%	178
2020 Q3	$432K	Hold	11,802	–	–	0.03%	178
2020 Q2	$400K	Buy	+11,802	New	+$322K	0.03%	182

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

McKinley Capital Management's GMAB Position: Q4 2023 in Review

McKinley Capital Management sold out of Genmab (GMAB) in Q4 2023, closing a stake of 8,058 shares — an estimated $284K sold.

McKinley Capital Management first reported a position in GMAB in Q2 2020 and held it in 8 quarters. The position peaked at $555K in Q4 2022. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

McKinley Capital Management reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
McKinley Capital Management sold 8,058 Genmab shares in Q4 2023, an estimated $284K.
McKinley Capital Management first reported a position in Genmab in Q2 2020 and held it in 8 quarters.
McKinley Capital Management's Genmab position peaked at $555K in Q4 2022.
225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on McKinley Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.